Frequency of Attention Deficit Hyperactivity Disorder (ADHD) using Screening (ASRS Screening) in patients attending the Hospital de Clínicas 2022
Keywords:
Attention Deficit Disorders with Hyperactivity, Functional Neuroimaging, Surveys and QuestionnairesAbstract
Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is characterized by a pattern of behaviors that include inattention and/or hyperactivity-impulsivity. Individuals with ADHD often develop low self-esteem and encounter academic challenges. The importance of biophysics is highlighted, as it helps decipher the neurobiological bases of the disorder. The aim of this study is to estimate the frequency of ADHD in patients attending the Hospital de Clínicas in San Lorenzo, Paraguay.
Methodology: This observational, descriptive cross-sectional study utilized a non-probabilistic convenience sampling method in September 2022, involving consecutive patients visiting the Hospital de Clínicas in San Lorenzo, Paraguay. Data was initially compiled using Microsoft Office Excel 2016 and subsequently transferred to PSPP software for processing and calculation of measures. To address our question regarding the frequency of ADHD in patients attending the Hospital de Clínicas, the instrument used was the Attention Deficit Hyperactivity Disorder Self-Report Scale (ASRS v.1.1) in its abbreviated six-item version.
Results: A total of 339 patients were included, with 78.5% of the respondents being female. All incomplete forms were excluded. Regarding residency, 46.6% lived in the Central Department. The mean age was 38.11±13.914 years. The average score on the ASRS screening was 2.43 points. A presumptive result of ADHD was found in 27.1% of the patients.
Conclusion: ADHD is a common disorder among adult patients and is underrecognized in Paraguay. It is more frequent in females than in males. Males scored higher on the ASRS questionnaire. Additionally, patients with ADHD predominantly came from the Central Department.
Downloads
References
(1) Asociación Americana de Psiquiatría, Guía de consulta de los criterios diagnósticos del DSM 5. Arlington, VA, Asociación Americana de Psiquiatría, 2013.
(2) Albrecht B, Uebel-Von Sandersleben H, Gevensleben H, Rothenberger A. Pathophysiology of ADHD and associated problems—starting points for NF interventions? Front Hum Neurosci [Internet].2015 [citado el 24 de septiembre de 2022];9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478393/
(3) Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child [Internet].2005 [citado el 24 de septiembre de 2022];90(suppl 1):i2–7. Disponible en: https://adc.bmj.com/content/90/suppl_1/i2
(4) Sánchez M, Lavigne R, Romero JF, Elósegui E. Emotion Regulation in Participants Diagnosed With Attention Deficit Hyperactivity Disorder, Before and After an Emotion Regulation Intervention. Front Psychol [Internet]. 2019 [citado el 24 de septiembre de 2022];10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543912/
(5) Beaton DM, Sirois F, Milne E. Experiences of criticism in adults with ADHD: A qualitative study. PLoS One [Internet].2022 [citado el 24 de septiembre de 2022];17(2):Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263366
(6) Sayal K, Prasad V, Daley D, Ford T, Coghill D. ADHD in children and young people: prevalence, care pathways, and service provision. The lancet Psychiatry [Internet]. el 1 de febrero de 2018 [citado el 25 de septiembre de 2022];5(2):175–86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29033005/
(7) Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health [Internet]. 2021 [citado el 25 de septiembre de 2022];11:1–9. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916320/
(8) Vos M, Hartman CA. The decreasing prevalence of ADHD across the adult lifespan confirmed. J Glob Health.2022;12:03024.
(9) Polanczyk G V., Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol [Internet]. 2014 [citado el 25 de septiembre de 2022];43(2):434. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817588/
(10) Torales J, Kadhum M, Zárate G, Barrios I, González I, Farrell SM, et al. Wellbeing and mental health among medical students in Paraguay. Int Rev Psychiatry [Internet]. el 17 de noviembre de 2019 [citado el 26 de septiembre de 2022];31(7–8):598–602. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31592689/
(11) Kessler, Ronald C., Lenard Adler, Minnie Ames, Olga Demler, Steve Faraone, Eva Hiripi, Mary J. Howes, et al. «The World Health Organization Adult ADHD Self-Report Scale (ASRS): A Short Screening Scale for Use in the General Population». Psychological Medicine 35, n.o 2 (febrero de 2005): 245-56. https://doi.org/10.1017/s0033291704002892.
(12) Pereira-Sanchez, Victor, y Francisco X. Castellanos. «Neuroimaging in Attention-Deficit/Hyperactivity Disorder». Current Opinion in Psychiatry 34, n.o 2 (1 de marzo de 2021): 105-11. https://doi.org/10.1097/YCO.0000000000000669.
(13) Adler LA, Spencer T, Faraone S V., Kessler RC, Howes MJ, Biederman J, et al. Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry [Internet]. 2006 [citado el 28 de septiembre de 2022];18(3):145–8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16923651/
(14) Ramos-Quiroga JA, Daigre C, Valero S, Bosch R, Gómez-Barros N, Nogueira M, Palomar G, Roncero C, Casas M. Validación al español de la escala de cribado del trastorno por déficit de atención/hiperactividad en adultos (ASRS v. 1.1): una nueva estrategia de puntuación. Rev Neurol 2009;48 (09):449-452
(15) National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management. Natl Inst Heal Clin Excell [Internet]. 2019 [citado el 20 de septiembre de 2022];62. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK493361/
(16) Ramos-Quiroga JA, Casas Brugué M. ¿Prestamos suficiente atención al déficit de atención con hiperactividad en adultos? Aten Primaria [Internet]. febrero de 2009 [citado el 10 de octubre de 2022];41(2):67. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022014/
(17) Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: Classification and criteria changes. World Psychiatry [Internet]. junio de 2013 [citado el 10 de octubre de 2022];12(2):92–8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23737408/
(18) Geffen J, Forster K. Treatment of adult ADHD: a clinical perspective. Ther Adv Psychopharmacol [Internet]. enero de 2018 [citado el 10 de octubre de 2022];8(1):25. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761907/
(19) Candar MG. Validez y fiabilidad de las escalas ASRS y WURS-25 para el diagnóstico del trastorno por déficit de atención/hiperactividad en población argentina. Rev Neurol 2021;72 (03):77-84
(20) Cahill BS, Coolidge FL, Segal DL, Klebe KJ, Marle PD, Overmann KA. Prevalence of ADHD and its subtypes in male and female adult prison inmates. Behav Sci Law. 2012 Mar-Apr;30(2):154-66
(21) Willcutt EG. The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. Neurotherapeutics [Internet]. julio de 2012 [citado el 10 de octubre de 2022];9(3):490. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441936/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Cecilia Ariane Ubaldi Cowan, Ana Gabriela Vargas Ayala, Lucas Daniel Vázquez Arrúa, Arturo Gerardo Vázquez Ferreira, Lara Luján Veran San Miguel, Naila Camila Villalba Fernández, Jessica Analía Villalba Fernández, Gabriel Gustavo Zárate Greco, Eric Hernán Benegas Sosa
This work is licensed under a Creative Commons Attribution 4.0 International License.
